Pharmagreen Biotech Inc. financial data

Symbol
PHBI on OTC
Industry
Airports, Flying Fields & Airport Terminal Services
Location
2987 Blackbear Court, Coquitlam, British Columbia, Canada
State of incorporation
NV
Fiscal year end
September 30
Former names
Air Transport Group Holdings, Inc. (to 2/3/2017), Azure International, Inc. (to 9/2/2008)
Latest financial report
10-Q - Q2 2023 - Aug 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -112 % +2.94%
Return On Equity 46.9 % -80%
Return On Assets -461 % +78.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 455M shares +12.5%
Common Stock, Shares, Outstanding 464M shares +9.32%
Entity Public Float 6.51M USD -28.9%
Common Stock, Value, Issued 464K USD +9.32%
Weighted Average Number of Shares Outstanding, Basic 404M shares +37.5%
Weighted Average Number of Shares Outstanding, Diluted 613M shares +74.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 597 USD
General and Administrative Expense 30K USD -62.2%
Operating Income (Loss) -231K USD +86.8%
Nonoperating Income (Expense) -823K USD +84.7%
Net Income (Loss) Attributable to Parent -163K USD -165%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 24.3K USD +26.2%
Accounts Receivable, after Allowance for Credit Loss, Current 606 USD +91.8%
Inventory, Net 9.25K USD
Assets, Current 51.5K USD
Assets 140K USD -26.6%
Accounts Payable, Current 697K USD +12.1%
Liabilities, Current 2.17M USD +9.1%
Liabilities 2.29M USD +7.63%
Accumulated Other Comprehensive Income (Loss), Net of Tax 48.3K USD +284%
Retained Earnings (Accumulated Deficit) -13M USD -4.02%
Stockholders' Equity Attributable to Parent -2.1M USD -11.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -2.15M USD -11%
Liabilities and Equity 140K USD -26.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.5K USD +86.9%
Net Cash Provided by (Used in) Financing Activities 47.4K USD -65.1%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 464M shares +9.32%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 16.9K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.32K USD -78.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 2.09M USD +8.03%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -51.5K USD -417%
Deferred Tax Assets, Operating Loss Carryforwards 2.03M USD +8.26%
Preferred Stock, Shares Issued 10K shares 0%
Preferred Stock, Shares Authorized 1M shares 0%
Additional Paid in Capital 10.3M USD +2.28%
Preferred Stock, Shares Outstanding 10K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%